2022 SMEnterprise Technology Innovation Development Project

633753
May 23, 2022
1 min read

Celltium Corporation has been chosen to participate in the 'Market Expansion Type' of the 2022 Small and Medium Enterprise Technology Innovation Development Project, organized by the Ministry of SMEs and Startups. The company will receive research and development funding and will conduct research on discovering treatments for Charcot-Marie-Tooth disease using a high-throughput, large-scale drug screening platform.

Recent Posts

See All

Installation and Operation of Genetically Modified Organism Research Facilities

Celltium Corporation has received confirmation from the Ministry of Science and ICT for the installation and operation of genetically...

Completion of Animal Experiment Facility Registration

Celltium Corporation has established animal breeding management and animal experiment facilities within its corporate-affiliated research...

'Neurological Disease New Drug Research' Celltium Inc. Secures First VC Investment of 5.5 Billion Won

Participated by 'Daekyo Investment, Korea Venture Investment, SL Investment', momentum in the non-clinical development of...